Literature DB >> 31801719

[Incidence and characteristics of benign liver space-occupying mass in 17 721 patients with chronic hepatitis B: a color Doppler ultrasound-based case-control study].

Yanyu Ren1, Guosheng Yuan1, Yuchen Zhou2, Chengguang Hu1, Junwei Liu1, Muhammad Ikram Anwar1, Cuirong Tang1, Yuan Li1, Wenxuan Yu1, Yuanping Zhou1, Lin Lin Dai1.   

Abstract

OBJECTIVE: To analyze the incidence and risk factors of benign liver space-occupying mass in patients with chronic hepatitis B (CHB) and the ultrasound features that differentiate these masses from small hepatocellular carcinoma.
METHODS: We retrospectively analyzed the color Doppler and clinical data of 17 721 patients with CHB treated in the Hepatology Unit of Nanfang Hospital between January, 2016 and December, 2017. The data were compared with those of 21629 healthy control subjects undergoing routine physical examination in the Center of Heath Management of Nanfang Hospital during the same period.
RESULTS: Compared with the control subjects, the patients with CHB had significantly higher incidences of hepatic cysts (11.8% vs 8.7%, P < 0.05), hepatic hemangioma (8.2% vs 1.6%, P < 0.05) and hepatic cirrhosis nodules (20.6% vs 2.4%, P < 0.05). The incidences of hepatic cysts and cirrhosis nodules increased with age and was significantly higher in male than in female patients (P < 0.001). The highest incidence of hepatic hemangioma was found in CHB patients aged 30-49 years without a gender difference (P>0.05). Sonographically, the benign liver masses commonly showed homogeneous echo within the lesion with clear boundaries and regular shape. Hepatic hemangioma was distinctively hyperechoic in 83.32% (1579/1895) of the patients, while small hepatocellular carcinoma presented with weaker peripheral and internal blood flow signals with a lower flow velocity in the arteries and a higher flow velocity in the portal vein. Liver cirrhosis nodules mostly showed a mixture of strong and weak echoes (79.60%; 7637/9595) without blood flow signal within or around the nodule; an increased volume of the nodule accompanied by heterogeneous echoes within the nodule indicated an increased probability of malignant lesion. Hepatic cysts often displayed no echo within the lesion, but the echo could be enhanced posteriorly.
CONCLUSIONS: The patients with CHB are at a significantly higher risk of developing hepatic cysts, hepatic hemangiomas and hepatic cirrhosis nodules than the control population, and an older age and the male gender are associated with a higher incidence of hepatic cysts or cirrhosis. The differences in the sonographic and hemodynamic features can help to differentiate hepatic benign mass from malignant lesions, and kinetic changes in sonography can be used to monitor potential malignant transformation of the cirrhotic lesions.

Entities:  

Keywords:  benign liver mass; chronic hepatitis B; incidence

Mesh:

Year:  2019        PMID: 31801719      PMCID: PMC6867945          DOI: 10.12122/j.issn.1673-4254.2019.10.03

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  15 in total

1.  [The guideline of prevention and treatment for chronic hepatitis B: a 2015 update].

Authors:  Jin-Lin Hou; Wei lai
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2015-12

Review 2.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; María Reig; Jordi Bruix
Journal:  Lancet       Date:  2018-01-05       Impact factor: 79.321

3.  Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

Authors:  M Claudon; C F Dietrich; B I Choi; D O Cosgrove; M Kudo; C P Nolsøe; F Piscaglia; S R Wilson; R G Barr; M C Chammas; N G Chaubal; M-H Chen; D A Clevert; J M Correas; H Ding; F Forsberg; J B Fowlkes; R N Gibson; B B Goldberg; N Lassau; E L S Leen; R F Mattrey; F Moriyasu; L Solbiati; H-P Weskott; H-X Xu
Journal:  Ultraschall Med       Date:  2012-11-05       Impact factor: 6.548

Review 4.  Imaging of Hepatic Focal Nodular Hyperplasia: Pictorial Review and Diagnostic Strategy.

Authors:  Marco Dioguardi Burgio; Maxime Ronot; Giuseppe Salvaggio; Valérie Vilgrain; Giuseppe Brancatelli
Journal:  Semin Ultrasound CT MR       Date:  2016-08-12       Impact factor: 1.875

5.  Diagnosis and treatment of benign liver nodules: Brazilian Society of Hepatology (SBH) recommendations.

Authors:  Edna Strauss; Adalgisa de Souza Paiva Ferreira; Alex Vianey Callado França; Andre Castro Lyra; Fabio Marinho do Rego Barros; Ivonete Silva; José Huygens Parente Garcia; Edison Roberto Parise
Journal:  Arq Gastroenterol       Date:  2015-12

Review 6.  Recall strategies for patients found to have a nodule in cirrhosis: is there still a role for CEUS?

Authors:  Vito Cantisani; Emanuele David; Franca Maria Meloni; Christoph Frank Dietrich; Radu Badea; Daniela Messineo; Ferdiando D'Ambrosio; Fabio Pisgalia
Journal:  Med Ultrason       Date:  2015-12       Impact factor: 1.611

7.  Hepatic hemangioma in celiac patients: data from a large consecutive series.

Authors:  Sara Massironi; Federica Branchi; Roberta Elisa Rossi; Mirella Fraquelli; Luca Elli; Maria Teresa Bardella; Federica Cavalcoli; Dario Conte
Journal:  Gastroenterol Res Pract       Date:  2015-01-12       Impact factor: 2.260

8.  Cancer incidence and mortality in China, 2014.

Authors:  Wanqing Chen; Kexin Sun; Rongshou Zheng; Hongmei Zeng; Siwei Zhang; Changfa Xia; Zhixun Yang; He Li; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

9.  Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients.

Authors:  Tanja Eva-Maria Kaltenbach; Phillip Engler; Wolfgang Kratzer; Suemeyra Oeztuerk; Thomas Seufferlein; Mark Martin Haenle; Tilmann Graeter
Journal:  Abdom Radiol (NY)       Date:  2016-01

Review 10.  MR with Gd-EOB-DTPA in assessment of liver nodules in cirrhotic patients.

Authors:  Riccardo Inchingolo; Riccardo Faletti; Luigi Grazioli; Eleonora Tricarico; Marco Gatti; Anna Pecorelli; Davide Ippolito
Journal:  World J Hepatol       Date:  2018-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.